375 related articles for article (PubMed ID: 37628811)
1. Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms.
Pukoli D; Vécsei L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628811
[TBL] [Abstract][Full Text] [Related]
2. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of Neurodegeneration in Multiple Sclerosis].
Eliseeva DD; Zakharova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7. Vyp. 2):5-13. PubMed ID: 35912550
[TBL] [Abstract][Full Text] [Related]
4. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
[TBL] [Abstract][Full Text] [Related]
5. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Haider L; Simeonidou C; Steinberger G; Hametner S; Grigoriadis N; Deretzi G; Kovacs GG; Kutzelnigg A; Lassmann H; Frischer JM
J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1386-95. PubMed ID: 24899728
[TBL] [Abstract][Full Text] [Related]
7. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Faissner S; Plemel JR; Gold R; Yong VW
Nat Rev Drug Discov; 2019 Dec; 18(12):905-922. PubMed ID: 31399729
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.
Fischer MT; Sharma R; Lim JL; Haider L; Frischer JM; Drexhage J; Mahad D; Bradl M; van Horssen J; Lassmann H
Brain; 2012 Mar; 135(Pt 3):886-99. PubMed ID: 22366799
[TBL] [Abstract][Full Text] [Related]
9. The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis.
Kennedy PGE; George W; Yu X
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886931
[TBL] [Abstract][Full Text] [Related]
10. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.
van Noort JM; van den Elsen PJ; van Horssen J; Geurts JJ; van der Valk P; Amor S
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):68-81. PubMed ID: 21143143
[TBL] [Abstract][Full Text] [Related]
11. The central role of mitochondria in axonal degeneration in multiple sclerosis.
Campbell GR; Worrall JT; Mahad DJ
Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
[TBL] [Abstract][Full Text] [Related]
12. CSF1R signaling is a regulator of pathogenesis in progressive MS.
Hagan N; Kane JL; Grover D; Woodworth L; Madore C; Saleh J; Sancho J; Liu J; Li Y; Proto J; Zelic M; Mahan A; Kothe M; Scholte AA; Fitzgerald M; Gisevius B; Haghikia A; Butovsky O; Ofengeim D
Cell Death Dis; 2020 Oct; 11(10):904. PubMed ID: 33097690
[TBL] [Abstract][Full Text] [Related]
13. CD4 Deficiency Causes Poliomyelitis and Axonal Blebbing in Murine Coronavirus-Induced Neuroinflammation.
Chakravarty D; Saadi F; Kundu S; Bose A; Khan R; Dine K; Kenyon LC; Shindler KS; Das Sarma J
J Virol; 2020 Jul; 94(14):. PubMed ID: 32404525
[TBL] [Abstract][Full Text] [Related]
14. Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration.
Xue S; Lozinski BM; Ghorbani S; Ta K; D'Mello C; Yong VW; Dong Y
J Neurosci; 2023 Jun; 43(25):4725-4737. PubMed ID: 37208177
[TBL] [Abstract][Full Text] [Related]
15. Molecular signature of slowly expanding lesions in progressive multiple sclerosis.
Jäckle K; Zeis T; Schaeren-Wiemers N; Junker A; van der Meer F; Kramann N; Stadelmann C; Brück W
Brain; 2020 Jul; 143(7):2073-2088. PubMed ID: 32577755
[TBL] [Abstract][Full Text] [Related]
16. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.
van Olst L; Rodriguez-Mogeda C; Picon C; Kiljan S; James RE; Kamermans A; van der Pol SMA; Knoop L; Michailidou I; Drost E; Franssen M; Schenk GJ; Geurts JJG; Amor S; Mazarakis ND; van Horssen J; de Vries HE; Reynolds R; Witte ME
Acta Neuropathol; 2021 Jun; 141(6):881-899. PubMed ID: 33779783
[TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration in multiple sclerosis.
Mey GM; Mahajan KR; DeSilva TM
WIREs Mech Dis; 2023 Jan; 15(1):e1583. PubMed ID: 35948371
[TBL] [Abstract][Full Text] [Related]
18. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
Kutzelnigg A; Lassmann H
Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of white matter damage in multiple sclerosis.
Lassmann H
Glia; 2014 Nov; 62(11):1816-30. PubMed ID: 24470325
[TBL] [Abstract][Full Text] [Related]
20. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
Simkins TJ; Duncan GJ; Bourdette D
Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
